Back to resultsCardiopulmonary Bypass (CPB) Pumps and Blood Activation
Primary Purpose
Cardiopulmonary Bypass, Coronary Artery Disease
Status
Unknown status
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
pumps used for cardiopulmonary bypass
Sponsored by
About this trial
This is an interventional treatment trial for Cardiopulmonary Bypass
Eligibility Criteria
Inclusion Criteria: Men undergoing coronary artery bypass grafting using cardiopulmonary bypass Aspirin therapy Exclusion Criteria: Redo surgery Acute coronary syndrome requiring urgent surgery Oral anticoagulant therapy Organ dysfunction or chronic inflammatory disease Surgery other than coronary artery bypass grafting
Sites / Locations
- University Hospital of AngersRecruiting
Outcomes
Primary Outcome Measures
Secondary Outcome Measures
Full Information
NCT ID
NCT00187967
First Posted
September 9, 2005
Last Updated
September 24, 2007
Sponsor
University Hospital, Angers
1. Study Identification
Unique Protocol Identification Number
NCT00187967
Brief Title
Cardiopulmonary Bypass (CPB) Pumps and Blood Activation
Official Title
Blood Activation During Cardiopulmonary Bypass Using Roller or Centrifugal Pumps
Study Type
Interventional
2. Study Status
Record Verification Date
September 2005
Overall Recruitment Status
Unknown status
Study Start Date
January 2005 (undefined)
Primary Completion Date
undefined (undefined)
Study Completion Date
undefined (undefined)
3. Sponsor/Collaborators
Name of the Sponsor
University Hospital, Angers
4. Oversight
5. Study Description
Brief Summary
Blood activation induced by cardiopulmonary bypass may compromise the postoperative outcome. The goal of this study is to compare blood activation induced by cardiopulmonary bypass performed with centrifugal pump or roller pump in patients undergoing coronary artery surgery.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Cardiopulmonary Bypass, Coronary Artery Disease
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Single
Allocation
Randomized
8. Arms, Groups, and Interventions
Intervention Type
Device
Intervention Name(s)
pumps used for cardiopulmonary bypass
10. Eligibility
Sex
Male
Minimum Age & Unit of Time
18 Years
Eligibility Criteria
Inclusion Criteria:
Men undergoing coronary artery bypass grafting using cardiopulmonary bypass
Aspirin therapy
Exclusion Criteria:
Redo surgery
Acute coronary syndrome requiring urgent surgery
Oral anticoagulant therapy
Organ dysfunction or chronic inflammatory disease
Surgery other than coronary artery bypass grafting
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Anthony Bailleul
Phone
33-(0)2-41-35-58-91
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Christophe Baufreton, MD, PhD
Organizational Affiliation
University Hospital of Angers, France
Official's Role
Principal Investigator
Facility Information:
Facility Name
University Hospital of Angers
City
Angers
ZIP/Postal Code
49933
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Christophe Baufreton, MD, PhD
Phone
33-(0)2-41-35-45-73
Email
ChBaufreton@chu-angers.fr
First Name & Middle Initial & Last Name & Degree
Anthony Bailleul
Phone
33-(0)2-41-35-58-91
12. IPD Sharing Statement
Learn more about this trial
Cardiopulmonary Bypass (CPB) Pumps and Blood Activation
We'll reach out to this number within 24 hrs